메뉴 건너뛰기




Volumn 38, Issue 8, 2000, Pages 381-386

Urinary excretion of vasoactive markers following estrogen replacement therapy in postmenopausal women

Author keywords

Estradiol substitution; Postmenopausal women; Urinary excretion; Vasoactive markers

Indexed keywords

2,3 DINOR 6 OXOPROSTAGLANDIN F1 ALPHA; 2,3 DINORTHROMBOXANE B2; 5 HYDROXYINDOLEACETIC ACID; CYCLIC GMP; ESTRADIOL; ESTRADIOL VALERATE; PROSTACYCLIN; RELAXIN; THROMBOXANE; VASOACTIVE AGENT;

EID: 0033837761     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP38381     Document Type: Article
Times cited : (13)

References (26)
  • 6
    • 85037934065 scopus 로고
    • Percutaneous administration of 17β-estradiol and oral administration of Premarin have different effects on urinary excretion of prostacyclin metabolites and serum high-density lipoproteins. 6. International Congress Menopause: Bangkok, Abstract No. 215
    • (1990)
    • Foidart, J.M.1    Dombrowicz, N.2    De Lignieres, B.3
  • 20
    • 0008221029 scopus 로고    scopus 로고
    • In vitro investigations to evaluate possible effects of sexual steroids on the vasculature
    • Lippert TH, Mueck AO, Ginsburg J (eds) Sex steroids and the cardiovascular system. Parthenon Publishing, London
    • (1998) , pp. 45-56
    • Seeger, H.1    Mueck, A.O.2    Lippert, T.H.3
  • 22
    • 0025981467 scopus 로고
    • Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
    • (1991) Prev Med , vol.20 , pp. 47-63
    • Stampfer, M.J.1    Colditz, G.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.